Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C. Scorsetti M, et al. Among authors: alongi f. Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145. Radiat Oncol. 2012. PMID: 22929062 Free PMC article.
The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II)--a survey among Italian radiation oncologists on radical radiotherapy in prostate cancer.
De Bari B, Alongi F, Franco P, Ciammella P, Chekrine T, Livi L, Jereczek-Fossa BA, Filippi AR; AIRO Young and AIRO Prostate cancer Working Group. De Bari B, et al. Among authors: alongi f. Radiol Med. 2013 Oct;118(7):1220-39. doi: 10.1007/s11547-013-0925-z. Epub 2013 May 27. Radiol Med. 2013. PMID: 23716281
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity.
Alongi F, Liardo RL, Iftode C, Lopci E, Villa E, Comito T, Tozzi A, Navarria P, Ascolese AM, Mancosu P, Tomatis S, Bellorofonte C, Arturo C, Scorsetti M. Alongi F, et al. Technol Cancer Res Treat. 2014 Oct;13(5):395-401. doi: 10.7785/tcrtexpress.2013.600268. Epub 2013 Aug 31. Technol Cancer Res Treat. 2014. PMID: 24000995 Free PMC article.
366 results